Subjective and objective symptoms in relation to plasma methadone concentration in methadone patients
- PMID: 7617797
- DOI: 10.1007/BF02245829
Subjective and objective symptoms in relation to plasma methadone concentration in methadone patients
Abstract
Two rating scales, which were originally developed for measurements of objective and subjective signs of opiate withdrawal, were used to evaluate potential estimates (correlates) of methadone effects in relation to plasma methadone concentrations. Patients participating in our regular methadone maintenance treatment project were studied during 24 h after the intake of the daily methadone dose. Methadone concentrations in plasma were compared to the subjective (estimated by the patients) and objective (estimated by the investigator) signs of the drug effects before, and 2.5, 5, 9 and 24 h after intake of methadone. Some new items possibly related to rising methadone concentrations were added to the subjective scale. Results indicated that, for subjective ratings, the majority of the items investigated corresponded well with the plasma methadone concentrations. The most significant associations were found for the following items: low psychomotor speed, alertness, running nose, yawning and anxiety. For objective ratings, only the items rhinorrhea, piloerection and signs of anxiety were significantly associated with the methadone concentrations. These rating scales may, together with plasma methadone determinations, be of considerable value when making dose adjustments for methadone maintenance patients. Further work is, however, needed to establish concentration-effect relationships.
Similar articles
-
Steady-state pharmacokinetics and pharmacodynamics in methadone maintenance patients: comparison of those who do and do not experience withdrawal and concentration-effect relationships.Clin Pharmacol Ther. 1999 Jun;65(6):685-94. doi: 10.1016/S0009-9236(99)90090-5. Clin Pharmacol Ther. 1999. PMID: 10391674
-
Craving despite extremely high methadone dosage.Drug Alcohol Depend. 1996 Mar;40(3):181-4. doi: 10.1016/0376-8716(95)01207-9. Drug Alcohol Depend. 1996. PMID: 8861396
-
Three oral formulations of methadone. A clinical and pharmacodynamic comparison.J Subst Abuse Treat. 1999 Oct;17(3):237-41. doi: 10.1016/s0740-5472(99)00008-2. J Subst Abuse Treat. 1999. PMID: 10531630 Clinical Trial.
-
Rated well-being in relation to plasma concentrations of l- and d-methadone in satisfied and dissatisfied patients on methadone maintenance treatment.Psychopharmacology (Berl). 1999 Apr;143(4):385-93. doi: 10.1007/s002130050963. Psychopharmacology (Berl). 1999. PMID: 10367556
-
Two new rating scales for opiate withdrawal.Am J Drug Alcohol Abuse. 1987;13(3):293-308. doi: 10.3109/00952998709001515. Am J Drug Alcohol Abuse. 1987. PMID: 3687892 Clinical Trial.
Cited by
-
Comparison of tincture of opium and methadone to control opioid withdrawal in a Thai treatment centre.Br J Clin Pharmacol. 2004 Nov;58(5):536-41. doi: 10.1111/j.1365-2125.2004.02209.x. Br J Clin Pharmacol. 2004. PMID: 15521902 Free PMC article. Clinical Trial.
-
Population pharmacokinetics and pharmacokinetic-pharmacodynamic relationships of methadone in a sample of Iranian (mazandarani) opiate users undergoing methadone maintenance treatment.Iran J Psychiatry Behav Sci. 2011 Fall;5(2):53-61. Iran J Psychiatry Behav Sci. 2011. PMID: 24644447 Free PMC article.
-
Affective and neuroendocrine effects of withdrawal from chronic, long-acting opiate administration.Brain Res. 2013 Nov 13;1538:73-82. doi: 10.1016/j.brainres.2013.09.026. Epub 2013 Sep 26. Brain Res. 2013. PMID: 24076207 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical